Arrowhead Pharmaceuticals, Inc.ARWRNASDAQ
LOADING
|||
Switch Symbol:
Cash Generation Expanding
Trending higher, above historical average.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$156.89M
↑ 272% above average
Average (9y)
$-91.44M
Historical baseline
Range
High:$161.03M
Low:$-604.32M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2025 | $156.89M | +126.0% |
| 2024 | $-604.32M | -82.8% |
| 2023 | $-330.63M | -75.0% |
| 2022 | $-188.91M | -227.9% |
| 2021 | $147.66M | +237.6% |
| 2020 | $-107.34M | -166.7% |
| 2019 | $161.03M | +431.0% |
| 2018 | $-48.64M | -52.7% |
| 2017 | $-31.86M | +53.3% |
| 2016 | $-68.29M | - |